Peptide N- and P/Q-type Ca2+ blockers inhibit stimulant-induced hyperactivity in mice

Peptides

Volumn 19, Issue 6, 1998, Pages 1017-1022

  Ogura, Hiroo ^a   Furuya, Yoshiaki ^a   Teramoto, Tetsuyuki ^a   Niidome, Tetsuhiro ^a   Nishizawa, Yukio ^a   Yamanishi, Yoshiharu ^a  

^a EISAI CO LTD   (Japan)

Author keywords

Calcium channel blocker; Hyperactivity; Mice; Psychostimulant

Indexed keywords

APOMORPHINE; BOVINE SERUM ALBUMIN; CALCIUM CHANNEL BLOCKING AGENT; DOPAMINE; DRUG VEHICLE; METHAMPHETAMINE; METHYLPHENIDATE; OMEGA AGATOXIN IVA; OMEGA CONOTOXIN GVIA; PHENCYCLIDINE; PSYCHOSTIMULANT AGENT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; HYPERACTIVITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CENTRAL NERVOUS SYSTEM STIMULANTS; HYPERKINESIS; INJECTIONS, INTRAVENTRICULAR; METHAMPHETAMINE; METHYLPHENIDATE; MICE; MOTOR ACTIVITY; OMEGA-AGATOXIN IVA; OMEGA-CONOTOXIN GVIA; PEPTIDES; PHENCYCLIDINE; SPIDER VENOMS;

ANIMALIA; BOVINAE; IVA;

EID: 0031830334     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00058-8     Document Type: Article

References (31)

1. Allen, M.; Young, S. Phencyclidine induced psychosis. Am. J. Psychiatry. 135:1081-1084; 1978.
2. Bunney, B. G.; Bunney, Jr., W. E.; Carlsson, A. In: Bloom, F. E.; Kupfer, D. J.; eds. Psychopharmacology: The fourth generation of progress. Schizophrenia and glutamate. New York: Raven Press, Ltd.; 1995:1205-1214.
3. Butcher, S. P.; Liptrot, J.; Arbuthnott, G. W. Characterization of methylphenidate and nomifensine induced dopamine release in rat striatum using in vivo brain microdialysis. Neurosci. Lett. 122:245-248; 1991.
4. Carboni, E.; Imperato, A.; Perezzani, L.; Di Chiara, G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience. 28: 653-661; 1989.
5. Catterall, W. A. Structure and function of voltage-gated ion channels. Annu. Rev. Biochem. 64:493-531; 1995.
6. Dooley, D. J.; Lupp, A.; Hertting, G. Inhibition of central neurotransmitter release by ω-conotoxin GVIA, a peptide modulator of the N-type voltage-sensitive calcium channel. Arch. Pharmacol. 336:467-470; 1987.
7. French, E. D.; Vantini, G. Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants. Psychopharmacology. 82:83-88; 1984.
8. Gaur, S.; Newcomb, R.; Rivnay, B.; Bell, JR.; Yamamoto, D.; Ramachandran, J.; Miljanich, G. P. Calcium channel antagonist peptides define several components of transmitter release in the hippocampus. Neuropharmacology. 33:1211-1219; 1994.
9. Gleason, S. D.; Shannon, H. E. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology. 129:79-84; 1997.
10. Haley, T. J.; McCormick, W. G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. 12: 12-15; 1957.
11. 2+ channel diversity. Annu. Rev. Neurosci. 17:399-418; 1994.
12. Ikeda, M.; Nakazawa, T.; Abe, K.; Kaneko, T.; Yamatsu, K. Extracellular accumulation of glutamate in the hippocampus induced by ischemia is not calcium dependent. Neurosci. Lett. 96:202-206; 1989.
13. Kato, T.; Otsu, Y.; Furune, Y.; Yamamoto, T. Different effects of L-, N- and T-type calcium channel blockers on striatal dopamine release measured by microdialysis in freely moving rats. Neurochem. Int. 21:99-107; 1992.
14. Kimura, M.; Yamanishi, Y.; Hanada, T.; Kagaya, T.; Kuwada, M.; Watanabe, T.; Katayama, K.; Nishizawa, Y. Involvement of P-type calcium channels in high potassium-elicited release of neurotransmitters from rat brain slices. Neuroscience. 66: 609-615; 1995.
15. Kuczenski, R. Biochemical actions of amphetamine and other stimulants. In: Creese, I.; ed. Central nervous system pharmacology: stimulants: neurochemical, behavioral, and clinical perspectives. New York: Raven Press; 1983:31-61.
16. Llinas, R.; Steinberg, I. Z.; Walton, K. Relationship between prepynaptic calcium current and postsynaptic potential in squid giant synapse. Biophys. J. 33:323-352; 1981.
17. Luby, E. D.; Cohen, B. O.; Rosenbaum, G.; Gottlieb, J. S.; Kelley, R. Study of a new schizophrenimetic drug - Sernyl. Am. Med. Assoc. Arch. Neurol. Psychiatry. 119:61-67; 1959.
18. Malmberg, A. B.; Yaksh, T. L. Voltage-sensitive calcium channels in spinal nociceptive processing: Blockade of N- and P-type channels inhibits formalin-induced nociception. J. Neurosci. 14:4882-4890; 1994.
19. Mintz, I. M.; Venema, V. J.; Swiderek, K. M.; Lee, T. D.; Bean, B. P.; Adams, M. E. P-type calcium channels blocked by the spider toxin ω-Aga-IVA. Nature (London). 355:827-829; 1992.
20. Nomikos, G. G.; Damsma, G.; Wenkstern, D.; Fibiger, H. C. In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse. 6:106-112; 1990.
21. Olivera, B. M.; Gray, W. R.; Zeikus, R.; McIntosh, L. M.; Varga, J.; Rivier, J.; Santos, V.; Cruz, L. J. Peptide neurotoxins from fish-hunting cone snails. Science (Washington DC). 230:1338-1343; 1985.
22. Ooboshi, H.; Sadoshima, S.; Yao, H.; Nakahara, T.; Uchimura, H.; Fujishima, M. Inhibition of ischemia-induced dopamine release by ω-conotoxin, a calcium channel blocker, in the striatum of spontaneous hypertensive rats: In vivo brain dialysis study. J. Neurochem. 58:298-303; 1992.
23. 2+ channel currents in rat cerebellar granule neurons. J. Neurosci. 15:2995-3012; 1995.
24. Rittenhouse, A. R.; Zigmond, R. E. ω-Conotoxin inhibits the acute activation of tyrosine hydroxylase and the stimulation of norepinephrine release by potassiun depolarization of sympathetic nerve endings. J. Neurochem. 56;615-622; 1991.
25. Swerdlow, N. R.; Vaccarino, F. J.; Amalric, M.; Koob, G. F. The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings. Pharmacol. Biochem. Behav. 25:233-248; 1986.
26. Takemura, M.; Kiyama, H.; Fukui, H.; Tohyama, M.; Wada, H. Distribution of the ω-conotoxin receptor in rat brain. An autoradiographic mapping. Neuroscience. 32: 405-416; 1989.
27. 2+-channels: four subtypes of α1- and β-subunits in developing and mature rat brain. Mol. Brain Behav. 30:1-16; 1995.
28. 1A subunits of brain calcium channels. J. Neurosci. 14:6403-6418; 1995.
29. Woods, S. K.; Meyer, J. S. Exogenous tyrosine potentiates the methylphenidate-induced increase in extracellular dopamine in the nucleus accumbens: a microdialysis study. Brain Res. 560:97-105; 1991.
30. Yamada, K.; Teraoka, T.; Morita, S.; Hesegawa, T.; Nabeshima, T. ω-Conotoxin GVIA inhibits the methylphenidate-induced but not methamphetamine-induced behavior. Neurosci. Lett. 165:191-194; 1994.
31. Zetterstrom, T.; Sharp, T.; Collin, A. K.; Ungerstedt, U. In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs: implications for the origin of extracellular DOPAC. Eur. J. Pharmacol. 148:327-334; 1988.